HK shares ETFs Daily Report: Gold Miners Surge Over 7%! Biomedicine Launches Broad Counterattack, STAR 50 and Semiconductors Edge Lower - 20260820

On August 20, 2026, gold miner and biomedicine ETFs in the HK shares market surged across the board. The E Fund (HK) Solactive Global Gold Miner Select Index ETF (2824.HK) rose 7.12% and the E Fund (HK) Solactive Biopharma Select Index ETF (3186.HK) rose 5.73%; the Premia China STAR50 ETF (3151.HK) fell 1.27%, with STAR 50 and clean energy ETFs pulling back slightly. NewTimeSpace monitoring shows a clear rotation pattern of a broad pharmaceutical and gold counterattack with STAR 50 and A50 under pressure.

NewTimeSpace News: On August 20, 2026, the HK shares ETFs market showed broad gains in gold miners, biomedicine, blockchain and Korea-related products, while STAR 50, clean energy and A50 products pulled back slightly, reflecting a structurally divergent pattern in the Hong Kong market.

Gold miner and biomedicine themes performed extremely strongly on the day. The E Fund (HK) Solactive Global Gold Miner Select Index ETF (2824.HK) rose 7.12%, leading the gainers after having been absent from the gainers list the previous day amid recent high volatility; the E Fund (HK) Solactive Biopharma Select Index ETF (3186.HK) rose 5.73%; the ChinaAMC Hang Seng Hong Kong Biotech Index ETF (3069.HK) rose 4.38%; the Global X China MedTech ETF (2841.HK) rose 4.11%; the CSOP Hang Seng Biotech ETF (3174.HK) rose 4.11%.

The blockchain direction was also active in tandem: the Samsung Blockchain Technologies ETF (3171.HK) rose 3.45%; the Global X China Biotech ETF (2820.HK) rose 3.39%; the E Fund (HK) Wind Digital Technology Index ETF (3434.HK) rose 2.64%; the Xtrackers MSCI Korea UCITS ETF (2848.HK) rose 2.38%; the Pando Blockchain ETF (3112.HK) rose 2.30%. Overall, gold miners, biomedicine and blockchain formed a clear sector linkage effect, with all top 10 gainers up more than 2.3% and the pharmaceutical sector launching a broad counterattack.

HK shares ETFs Top 10 Gainers

No.

Code

Name

Change (%)

Tracking Index

Manager

1

2824.HK

E Fund (HK) Solactive Global Gold Miner Select Index ETF

7.12

--

E Fund Asset Management (Hong Kong) Limited

2

3186.HK

E Fund (HK) Solactive Biopharma Select Index ETF

5.73

--

E Fund Asset Management (Hong Kong) Limited

3

3069.HK

ChinaAMC Hang Seng Hong Kong Biotech Index ETF

4.38

Hang Seng Hong Kong-Listed Biotech Index

China Asset Management (Hong Kong)

4

2841.HK

Global X China MedTech ETF

4.11

Solactive China MedTech Index (Net Total Return)

Mirae Asset Global Investments (Hong Kong)

5

3174.HK

CSOP Hang Seng Biotech ETF

4.11

Hang Seng Hong Kong-Listed Biotech Index

CSOP Asset Management Limited

6

3171.HK

Samsung Blockchain Technologies ETF

3.45

--

Samsung Asset Management (Hong Kong) Limited

7

2820.HK

Global X China Biotech ETF

3.39

Solactive China Biotech Index (Net Total Return)

Mirae Asset Global Investments (Hong Kong)

8

3434.HK

E Fund (HK) Wind Digital Technology Index ETF

2.64

Wind Digital Technology Net Total Return Index (HKD)

E Fund Asset Management (Hong Kong) Limited

9

2848.HK

Xtrackers MSCI Korea UCITS ETF

2.38

--

DWS Investment S.A.

10

3112.HK

Pando Blockchain ETF

2.30

--

Pando Limited

Source/Compiled by: Wind / NewTimeSpace, as of the close onAugust 20, 2026

Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted.

On the downside, the STAR 50 and clean energy sectors led the declines, though losses were modest overall. The Premia China STAR50 ETF (3151.HK) fell 1.27%, the steepest decline; the Global X China Clean Energy ETF (2809.HK) fell 1.11%; the Global X China Semiconductor ETF (3191.HK) fell 1.01%; the CSOP STAR 50 Index ETF (3109.HK) fell 0.98%; the Bosera STAR 50 Index ETF (2832.HK) fell 0.91%; the iShares FTSE China A50 ETF (2823.HK) fell 0.89%; the AMUNDI FTSE China A50 Index ETF (2843.HK) fell 0.51%; the W.I.S.E. - SSE 50 China Tracker (3024.HK) fell 0.45%; the iShares Core MSCI Taiwan Index ETF (3074.HK) fell 0.40%; the Fubon ICE FactSet Taiwan Core Semiconductor Index ETF (3076.HK) fell 0.39%. STAR 50, clean energy, China semiconductor and A50 products came under pressure on the day, with none of the declines exceeding 1.3%, indicating limited pullback.

HK shares ETFs Top 10 Decliners

No.

Code

Name

Change (%)

Tracking Index

Manager

1

3151.HK

Premia China STAR50 ETF

-1.27

SSE STAR 50 Index

Premia Partners

2

2809.HK

Global X China Clean Energy ETF

-1.11

Solactive China Clean Energy Index (Net Total Return)

Mirae Asset Global Investments (Hong Kong)

3

3191.HK

Global X China Semiconductor ETF

-1.01

FactSet China Semiconductor Index (Net Total Return)

Mirae Asset Global Investments (Hong Kong)

4

3109.HK

CSOP STAR 50 Index ETF

-0.98

SSE STAR 50 Index

CSOP Asset Management Limited

5

2832.HK

Bosera STAR 50 Index ETF

-0.91

SSE STAR 50 Index

Bosera Asset Management (International)

6

2823.HK

iShares FTSE China A50 ETF

-0.89

FTSE China A50 Index

BlackRock Asset Management North Asia Limited

7

2843.HK

AMUNDI FTSE China A50 Index ETF

-0.51

FTSE China A50 Index

Amundi Hong Kong Limited

8

3024.HK

W.I.S.E. - SSE 50 China Tracker

-0.45

SSE 50 Index

BOCI-Prudential Asset Management Limited

9

3074.HK

iShares Core MSCI Taiwan Index ETF

-0.40

MSCI Taiwan Index

BlackRock Asset Management North Asia Limited

10

3076.HK

Fubon ICE FactSet Taiwan Core Semiconductor Index ETF

-0.39

ICE FactSet Taiwan Core Semiconductor 10% OTC Weight Cap Index

Fubon Fund Management (Hong Kong) Limited

Source/Compiled by: Wind / NewTimeSpace, as of the close onAugust 20, 2026

Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted.

NewTimeSpace Research data shows that on August 20, 2026, the HK shares ETFs market exhibited a rotation pattern of a broad pharmaceutical and gold counterattack with modest pressure on STAR 50 and A50 products. Gold miners, biomedicine and blockchain attracted concentrated buying and led the gains, while STAR 50, clean energy and A50 products pulled back slightly. Market hotspots swiftly rotated from the previous day's high-dividend defensive space to gold miners and biomedicine; after a period of prior adjustment, the pharmaceutical sector again launched a broad counterattack and became the day's absolute main theme, while the STAR 50 and A50 directions continued their correction, with sector rotation still rapid.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.